Aster DM Healthcare Limited (ASTERDM) - Net Assets
Based on the latest financial reports, Aster DM Healthcare Limited (ASTERDM) has net assets worth Rs48.34 Billion INR (≈ $522.75 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs81.12 Billion ≈ $877.28 Million USD) and total liabilities (Rs32.78 Billion ≈ $354.53 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check ASTERDM strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs48.34 Billion |
| % of Total Assets | 59.59% |
| Annual Growth Rate | 29.09% |
| 5-Year Change | 7.83% |
| 10-Year Change | 114.77% |
| Growth Volatility | 192.97 |
Aster DM Healthcare Limited - Net Assets Trend (2011–2026)
This chart illustrates how Aster DM Healthcare Limited's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Aster DM Healthcare Limited (ASTERDM) total market value.
Annual Net Assets for Aster DM Healthcare Limited (2011–2026)
The table below shows the annual net assets of Aster DM Healthcare Limited from 2011 to 2026. Also explore ASTERDM net assets growth trend to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2026-03-31 | Rs48.34 Billion ≈ $522.75 Million |
+32.38% |
| 2025-03-31 | Rs36.51 Billion ≈ $394.89 Million |
-27.41% |
| 2024-03-31 | Rs50.30 Billion ≈ $543.99 Million |
+3.49% |
| 2023-03-31 | Rs48.60 Billion ≈ $525.64 Million |
+8.43% |
| 2022-03-31 | Rs44.83 Billion ≈ $484.78 Million |
+16.91% |
| 2021-03-31 | Rs38.34 Billion ≈ $414.65 Million |
+3.11% |
| 2020-03-31 | Rs37.19 Billion ≈ $402.14 Million |
+1.05% |
| 2019-03-31 | Rs36.80 Billion ≈ $397.96 Million |
+15.35% |
| 2018-03-31 | Rs31.90 Billion ≈ $344.99 Million |
+41.74% |
| 2017-03-31 | Rs22.51 Billion ≈ $243.40 Million |
+277.21% |
| 2016-03-31 | Rs5.97 Billion ≈ $64.53 Million |
-73.44% |
| 2015-03-31 | Rs22.46 Billion ≈ $242.91 Million |
+63.88% |
| 2014-03-31 | Rs13.71 Billion ≈ $148.22 Million |
+19.98% |
| 2013-03-31 | Rs11.42 Billion ≈ $123.54 Million |
+28.78% |
| 2012-03-31 | Rs8.87 Billion ≈ $95.93 Million |
+745.76% |
| 2011-03-31 | Rs1.05 Billion ≈ $11.34 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Aster DM Healthcare Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 4896000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2026)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Rs5.18 Billion | 11.32% |
| Other Components | Rs40.58 Billion | 88.68% |
| Total Equity | Rs45.76 Billion | 100.00% |
Aster DM Healthcare Limited Competitors by Market Cap
The table below lists competitors of Aster DM Healthcare Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Franklin Electric Co Inc
NASDAQ:FELE
|
$4.22 Billion |
|
Shenzhen Suntak Circuit Technology Co Ltd
SHE:002815
|
$4.23 Billion |
|
Ecovacs Robotics Co Ltd
SHG:603486
|
$4.23 Billion |
|
Baic Bluepark New Energy Technology
SHG:600733
|
$4.23 Billion |
|
Joinn Laboratories(China)Co
SHG:603127
|
$4.22 Billion |
|
Bidvest Group Ltd
JSE:BVT
|
$4.22 Billion |
|
MDA Ltd
TO:MDA
|
$4.22 Billion |
|
K.P.R. Mill Limited
NSE:KPRMILL
|
$4.22 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Aster DM Healthcare Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from 34,280,700,000 to 45,758,600,000, a change of 11,477,900,000 (33.5%).
- Net income of 3,881,400,000 contributed positively to equity growth.
- Dividend payments of 518,700,000 reduced retained earnings.
- Other comprehensive income decreased equity by 8,580,900,000.
- Other factors increased equity by 16,696,100,000.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs3.88 Billion | +8.48% |
| Dividends Paid | Rs518.70 Million | -1.13% |
| Other Comprehensive Income | Rs-8.58 Billion | -18.75% |
| Other Changes | Rs16.70 Billion | +36.49% |
| Total Change | Rs- | 33.48% |
Book Value vs Market Value Analysis
This analysis compares Aster DM Healthcare Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 8.52x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 302.21x to 8.52x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-03-31 | Rs2.50 | Rs755.05 | x |
| 2012-03-31 | Rs17.90 | Rs755.05 | x |
| 2013-03-31 | Rs20.73 | Rs755.05 | x |
| 2014-03-31 | Rs24.22 | Rs755.05 | x |
| 2015-03-31 | Rs37.73 | Rs755.05 | x |
| 2016-03-31 | Rs8.95 | Rs755.05 | x |
| 2017-03-31 | Rs40.42 | Rs755.05 | x |
| 2018-03-31 | Rs60.43 | Rs755.05 | x |
| 2019-03-31 | Rs63.90 | Rs755.05 | x |
| 2020-03-31 | Rs65.07 | Rs755.05 | x |
| 2021-03-31 | Rs67.76 | Rs755.05 | x |
| 2022-03-31 | Rs79.42 | Rs755.05 | x |
| 2023-03-31 | Rs89.34 | Rs755.05 | x |
| 2024-03-31 | Rs91.56 | Rs755.05 | x |
| 2025-03-31 | Rs68.75 | Rs755.05 | x |
| 2026-03-31 | Rs88.65 | Rs755.05 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Aster DM Healthcare Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.48%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.36%
- • Asset Turnover: 0.57x
- • Equity Multiplier: 1.77x
- Recent ROE (8.48%) is below the historical average (16.22%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | -3.56% | -28.12% | 0.04x | 2.83x | Rs-126.83 Million |
| 2012 | 7.80% | 4.43% | 0.72x | 2.45x | Rs-147.37 Million |
| 2013 | 11.78% | 4.78% | 0.90x | 2.75x | Rs138.48 Million |
| 2014 | 19.53% | 6.19% | 0.99x | 3.18x | Rs867.29 Million |
| 2015 | 8.94% | 3.42% | 0.88x | 2.97x | Rs-157.48 Million |
| 2016 | -14.06% | -1.12% | 0.91x | 13.72x | Rs-1.01 Billion |
| 2017 | 5.43% | 1.75% | 0.85x | 3.63x | Rs-857.81 Million |
| 2018 | 9.49% | 4.06% | 0.88x | 2.64x | Rs-143.29 Million |
| 2019 | 10.37% | 4.27% | 0.87x | 2.78x | Rs117.34 Million |
| 2020 | 8.45% | 3.27% | 0.68x | 3.80x | Rs-506.04 Million |
| 2021 | 4.38% | 1.73% | 0.73x | 3.45x | Rs-1.90 Billion |
| 2022 | 13.30% | 5.13% | 0.82x | 3.17x | Rs1.31 Billion |
| 2023 | 9.55% | 14.39% | 0.20x | 3.35x | Rs-198.97 Million |
| 2024 | 2.84% | 3.55% | 0.20x | 3.95x | Rs-3.27 Billion |
| 2025 | 156.88% | 132.15% | 0.62x | 1.93x | Rs50.35 Billion |
| 2026 | 8.48% | 8.36% | 0.57x | 1.77x | Rs-694.46 Million |
Industry Comparison
This section compares Aster DM Healthcare Limited's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $23,213,294,222
- Average return on equity (ROE) among peers: 13.33%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Aster DM Healthcare Limited (ASTERDM) | Rs48.34 Billion | -3.56% | 0.68x | $4.22 Billion |
| Apollo Hospitals Enterprise Limited (APOLLOHOSP) | $58.78 Billion | 17.96% | 1.24x | $13.91 Billion |
| GPT Healthcare Ltd (GPTHEALTH) | $1.16 Billion | 12.91% | 1.22x | $147.49 Million |
| Healthcare Global Enterprises Limited (HCG) | $5.79 Billion | 3.54% | 1.49x | $1.14 Billion |
| Jupiter Life Line Hospitals Limited (JLHL) | $11.69 Billion | 15.11% | 0.10x | $992.88 Million |
| Krishna Institute of Medical Sciences Limited (KIMS) | $3.34 Billion | 9.75% | 1.32x | $3.50 Billion |
| Lotus Eye Hospital and Institute Limited (LOTUSEYE) | $151.10 Million | 8.52% | 0.57x | $25.89 Million |
| Max Healthcare Institute Limited (MAXHEALTH) | $107.47 Billion | 13.42% | 0.60x | $11.04 Billion |
| Max India Limited (MAXIND) | $7.06 Billion | 36.09% | 0.45x | $93.00 Million |
| Global Health Limited (MEDANTA) | $13.50 Billion | 2.69% | 0.98x | $4.36 Billion |
About Aster DM Healthcare Limited
Aster DM Healthcare Limited, together with its subsidiaries, provides healthcare services in India. It operates through Hospitals, Clinics, Wholesale Pharmacies, and Others segments. The company operates hospitals, clinic, and in-house pharmacies at the hospitals and clinics. It also offers healthcare consultancy and other services. In addition, the company operates retail pharmacies and optical … Read more